Biopsy Devices Market is poised to grow at a high CAGR of 6.5% during the forecast period (2018 - 2023)| Top Vendors - C R BARD, HOLOGIC, CAREFUSION, COOK MEDICAL, BOSTON SCIENTIFIC, TSK LABORATORY, amongst others

Market Analysis:

Asia-Pacific to have the Highest CAGR
The growth of Asia-Pacific can be attributed to the rising prevalence of cancer, large population in countries such as China and India, improving healthcare infrastructure, increasing healthcare spending and government initiatives, and rising focus of key market players in the region.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16820
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

A biopsy can be described as a process in which a sample tissue is removed from the body for analyzing or discovering the presence, cause, or extent of a disease. The key facts stated by WHO projects cancer to be one of the leading causes of mortality worldwide, with around 14 million new cases and 8.2 million cancer-related deaths in 2012. The demand for early detection of the cancer is going to influence the growth of the biopsy devices market in the world over. Increasing preference for minimally-invasive surgeries and initiatives undertaken by the government and global health organizations are some of the other factors contributing to the growth of the market.

Request Discount on this report @ https://marketprognosis.com/discount-request/16820
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Market Segments:
Biopsy Devices Market is segmented by:
1. Product: Needle-based biopsy Instruments, Procedure Trays, Localization Wires, Others
2. Application: Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others
3. Geography: North America, South America, Europe, Asia Pacific, Middle East & Africa

Key Developments in the Market
• August 2017: C. R. Bard Receives FDA pPremarket approval of the LUTONIXu00ae 035 drug coated balloon as the first and only DCB for the treatment of patients with dysfunctional AV fistulae
• August 2017: Hologic announced the availability of New Breverau00ae Breast Biopsy System, with CorLuminau00ae Imaging Technology

Enquiry before Buying @ https://marketprognosis.com/enquiry/16820
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today's complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.